Starbucks (SBUX) PT Raised to $120 at Cowen on Positive Survey
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
- J&J (JNJ) Privately Asked Rival Covid-19 Vaccine Makers to Inspect Clotting Risks, AstraZeneca (AZN) Said Yes but Pfizer (PFE) and Moderna (MRNA) Declined - Report
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Cowen analyst Andrew Charles raised the price target on Starbucks (NASDAQ: SBUX) to $120.00 (from $112.00) while maintaining an Outperform rating on positive survey results showing minimal change in anticipated coffee shop visitation vs. pre-COVID-19 levels.
The analyst commented, "We are encouraged by proprietary survey data suggesting minimal change in anticipated coffee shop visitation vs. pre-COVID-19 levels. We raise 2Q-4Q21E Americas comps in excess of Consensus Metrix, while 2021 revenue is also aided by nuanced modeling dynamics around store closures that give us confidence in upcoming beats & raises. We raise PT to $120; SBUX is our favorite "reopening" stock."
The firm raised 2Q-4Q21 Americas (~90% U.S.) same store sales from 7%, 76% and 14%; to 8%, 79% and 18%, respectively.
They raised raising 2021-23E EPS to $2.89, $3.50 and $4.02, from $2.85, $3.40 and $3.89, which is in excess of $2.83, $3.46 and $3.92 consensus, respectively
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Localiza Rent a Car S.A. (RENT3:BZ) (LZRFY) PT Lowered to R$67 at Morgan Stanley
- Trevali Mining Corp. (TV:CN) (TREVF) PT Raised to Cdn$0.18 at Canaccord Genuity
- BlueScope Steel Limited (BSL:AU) (BLSFY) PT Raised to AUD22.50 at Credit Suisse
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesCowen & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!